Literature DB >> 1454829

Malignancy of eye melanomas originating in the retinal pigment epithelium of transgenic mice after genetic ablation of choroidal melanocytes.

B Mintz1, A J Klein-Szanto.   

Abstract

Eye tumors of the retinal pigment epithelium (RPE) have been thought generally to be benign, whereas choroidal ones are malignant. To test this assumption in mice, the W/Wv (Kit) mutant genotype was introduced into melanoma-prone transgenic mice whose recombinant simian virus 40 transforming sequences are specifically expressed in pigment cells. W/Wv causes programmed death of neural crest-derived pigment cells, including choroidal ones, but leaves intact the brain-derived pigment cells, such as those in the RPE. Dysplastic cells arose in the RPE, contiguous with frank melanotic neoplasms. Invasion of the optic nerve, and tumor growth outside the orbit, attested to the malignancy of these RPE-derived melanomas. The widespread melanosis previously seen in mice with this transgene was absent when W/Wv was added, thus validating its chief origin from neural crest cells.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1454829      PMCID: PMC50562          DOI: 10.1073/pnas.89.23.11421

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  19 in total

1.  The occurrence and morphogenesis of melanocytes in the connective tissues of the PET/MCV mouse strain.

Authors:  S E NICHOLS; W M REAMS
Journal:  J Embryol Exp Morphol       Date:  1960-03

2.  Gene-induced embryological modifications of primordial germ cells in the mouse.

Authors:  B MINTZ; E S RUSSELL
Journal:  J Exp Zool       Date:  1957-03

3.  The Effects of Genotype and Cell Environment on Melanoblast Differentiation in the House Mouse.

Authors:  C L Markert; W K Silvers
Journal:  Genetics       Date:  1956-05       Impact factor: 4.562

4.  An improved method for isolation and culture of pigment epithelial cells from rat retina.

Authors:  C W Chang; R S Roque; D M Defoe; R B Caldwell
Journal:  Curr Eye Res       Date:  1991-11       Impact factor: 2.424

5.  Neonatal W-mutant mice are favorable hosts for tracking development of marked hematopoietic stem cells.

Authors:  B Capel; B Mintz
Journal:  Exp Hematol       Date:  1989-09       Impact factor: 3.084

6.  The relationship between abnormalities of pigmentation and of the inner ear.

Authors:  M S Deol
Journal:  Proc R Soc Lond B Biol Sci       Date:  1970-04-07

7.  Pathological condition of the retinal pigment epithelium. Neoplasms and nodular non-neoplastic lesions.

Authors:  M O Tso; D M Albert
Journal:  Arch Ophthalmol       Date:  1972-07

8.  Malignant melanoma in transgenic mice.

Authors:  M Bradl; A Klein-Szanto; S Porter; B Mintz
Journal:  Proc Natl Acad Sci U S A       Date:  1991-01-01       Impact factor: 11.205

9.  Morphologic diversity in malignant melanomas.

Authors:  R E Nakhleh; M R Wick; A Rocamora; P E Swanson; L P Dehner
Journal:  Am J Clin Pathol       Date:  1990-06       Impact factor: 2.493

10.  Molecular bases of dominant negative and loss of function mutations at the murine c-kit/white spotting locus: W37, Wv, W41 and W.

Authors:  K Nocka; J C Tan; E Chiu; T Y Chu; P Ray; P Traktman; P Besmer
Journal:  EMBO J       Date:  1990-06       Impact factor: 11.598

View more
  3 in total

1.  Changes in expression of putative antigens encoded by pigment genes in mouse melanomas at different stages of malignant progression.

Authors:  S J Orlow; V J Hearing; C Sakai; K Urabe; B K Zhou; W K Silvers; B Mintz
Journal:  Proc Natl Acad Sci U S A       Date:  1995-10-24       Impact factor: 11.205

2.  Transgenic mouse model of malignant skin melanoma.

Authors:  B Mintz; W K Silvers
Journal:  Proc Natl Acad Sci U S A       Date:  1993-10-01       Impact factor: 11.205

Review 3.  Hindsight: Review of Preclinical Disease Models for the Development of New Treatments for Uveal Melanoma.

Authors:  Caoimhe Goldrick; Letizia Palanga; Bobby Tang; Grace Mealy; John Crown; Noel Horgan; Susan Kennedy; Naomi Walsh
Journal:  J Cancer       Date:  2021-06-04       Impact factor: 4.207

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.